Atrial Fibrillation
Atrial fibrillation (AF) is a heart condition characterized by an irregular and often rapid heartbeat, which can lead to poor blood flow and increase the risk of stroke and heart-related complications.
Atrial Fibrillation: Amiodarone Treatment Study
We are studying whether a longer or shorter course of amiodarone helps people with persistent atrial fibrillation return to a normal heart rhythm before a procedure. This may improve outcomes for patients undergoing electrical cardioversion.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have persistent atrial fibrillation that has lasted for 7 days or more?
- Have you been referred for elective electrical cardioversion?
- Do you have a heart rate that is consistently below 50 beats per minute?
- Have you had any heart surgery that resulted in atrial fibrillation?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Amiodar
Amiodaron 1 A Pharma
Amiodaron Aurobindo
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Germans Trias I Pujol
Cardiologia
Badalona, Spain
Hospital De La Santa Creu I Sant Pau
Cardiologia
Fraga, Spain
Complexo Hospitalario Universitario De Santiago
Cardiologia
Santiago de Compostela, Spain
Sponsor: Institut D Investigacio Sanitaria Pere Virgili
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.